期刊文献+

急诊超声心动图联合血清NT-proBNP、cTnI、CK-MB诊断急性心肌梗死的临床价值分析 被引量:48

Clinical Value Analysis of Emergency Echocardiography Combined with Serum NT-proBNP, cTnI and CK-MB in the Diagnosis of Acute Myocardial Infarction
原文传递
导出
摘要 目的:研究急诊超声心动图联合血清氨基末端脑钠肽前体(NT-proBNP)、肌钙蛋白(cTnI)和肌酸激酶同工酶(CK-MB)诊断急性心肌梗死(AMI)的临床价值。方法:将2019年12月至2020年6月期间我院收治的82例AMI患者纳入研究,记作病变组。另取同期于我院进行体检的健康者80例作为对照组。比较两组各项超声心动图指标水平,血清NT-proBNP、cTnI和CK-MB水平。分析超声心动图指标与血清NT-proBNP、cTnI和CK-MB的相关性。以受试者工作特征(ROC)曲线分析超声心动图联合血清NT-pro BNP、cTnI和CK-MB水平诊断AMI的效能。结果:病变组左心室射血分数(LVEF)低于对照组,而左室舒张末期内径(LVEDD)高于对照组(P<0.05)。病变组血清NT-proBNP、cTnI和CK-MB水平均高于对照组(P<0.05)。Pearson检验显示LVEF与血清NT-proBNP、cTnI和CK-MB均呈负相关(r=-0.514、-0.578、-0.532,均P<0.05),LVEDD与血清NT-proBNP、cTnI和CK-MB均呈正相关(r=0.625、0.594、0.575,均P<0.05)。超声心动图联合血清三项诊断AMI的曲线下面积、灵敏度以及特异度均高于超声心动图、血清三项单独诊断。结论:超声心动图联合血清NT-proBNP、cTnI和CK-MB诊断AMI的价值较高,具有一定的临床应用价值。 Objective: To study the clinical value of emergency echocardiography combined with serum n-terminal brain natropeptide precursor(NT-proBNP), troponin(cTnI) and creatine kinase isoenzyme(CK-MB) in the diagnosis of acute myocardial infarction(AMI). Methods: 82 patients with AMI admitted to our hospital from December 2019 to June 2020 were included in the study,which were labeled as the lesion group. In addition, 80 healthy physical examinees in our hospital during the same period were selected as control group. The levels of echocardiography indexes, serum NT-proBNP, cTnI and CK-MB were compared between the two groups.The correlation between echocardiography and serum NT-proBNP, cTnI and CK-MB was analyzed. Receiver operating characteristic(ROC) curve was used to analyze the diagnostic efficacy of echocardiography combined with levels of serum NT-proBNP, cTnI and CK-MB in diagnosing AMI. Results: The left ventricular ejection fraction(LVEF) of the lesion group was lower than that of the control group, while the left ventricular end diastolic diameter(LVEDD) was higher than that of the control group(P<0.05). The levels of serum NT-pro BNP, cTnI and CK-MB of the lesion group were all higher than those of the control group(P<0.05). Pearson test showed that LVEF was negatively correlated with serum NT-proBNP, cTnI and CK-MB(r=-0.514,-0.578,-0.532;all P <0.05);LVEDD was positively correlated with serum NT-proBNP, cTnI and CK-MB(r=0.625, 0.594, 0.575;all P<0.05). The area under curve, sensitivity and specificity of echocardiography combined with serum three items in diagnosing AMI were all higher than those of the echocardiography and serum three items separate diagnosing. Conclusion: The value of echocardiography combined with serum NT-proBNP, cTnI and CK-MB in the diagnosis of AMI is relatively high, which has certain clinical application value.
作者 杨焕杰 完海平 杨永昌 杨冬 张宏斌 YANG Huan-jie;WAN Hai-ping;YANG Yong-chang;YANG Dong;ZHANG Hong-bin(Department of Emergency Medicine,The 942 Hospital of PLA,Yinchuan,Ningxia,750000,China)
出处 《现代生物医学进展》 CAS 2020年第21期4084-4087,共4页 Progress in Modern Biomedicine
基金 宁夏自然科学基金项目(NZ16241)。
关键词 急性心肌梗死 超声心动图 氨基末端脑钠肽前体 肌钙蛋白 肌酸激酶同工酶 Acute myocardial infarction Echocardiography N-terminal brain natropeptide precursor Troponin Creatine kinase isoenzyme
  • 相关文献

参考文献10

二级参考文献103

  • 1郑丽,黄国倩,王成.实时三维超声定量评价急性心肌梗死左室重构及功能[J].上海交通大学学报(医学版),2011,31(2):194-197. 被引量:11
  • 2白莲莲.肌红蛋白和肌钙蛋白I联合检测在急性心肌梗死中的临床意义[J].中国卫生产业,2013,10(2):127-128. 被引量:2
  • 3Brown DA, Breit SN, Buring J, et al. Concentration in plasma of macro- phage inhibitory cytokine-1 and risk of cardiovascular events in women : a nested case-control study[ J ]. Tan M, Wang Y, Guan K, et al Lancet ,2002,359 ( 9324 ) :2159-2163.
  • 4PTGF-beta, a type beta transforminggrowth factor (TGF-bcta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway [ J ]. Proc Natl Acad Sci USA ,2000,97 ( 1 ) : 109-114.
  • 5Kempf T, Eden M, Strelau J, et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury [ J ]. Cire Res, 2006,98 ( 3 ) : 351- 360.
  • 6Anand I S, Kempf T, Rector TS, et al. Serial measurement of growth-dif- ferentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial[ J]. Circulation,2010, 122 (14) : 1387-1395.
  • 7Johnen H, Kuffner T, Brown DA, et al. Increased expression of the TGF- b superfamily cytokine MIC-1/GDF15 protects ApoE (-/-) mice from the development of atherosclerosis [ J ]. Cardiovasc Pathol, 2012,21 (6) :499-505.
  • 8Bonaca MP, Morrow DA, Braunwald E, et al. Growth differentiation fac- tor-15 and risk of recurrent events in patients stabilized after acute coro- nary syndrome: observations from PROVE IT-TIMI 22[J]. ArteriosclerThromb Vasc Biol,2011,31 ( 1 ) :203-210.
  • 9Kempf T,Bj~rklund E, Olofsson S, et al. Growth-differentiation factor- 15 improves risk stratification in ST-segment elevation myocardial infarc- tion[J]. Eur Heart J,2007,28(23) :2858-2865.
  • 10Khan S,Dhillon K,Kelly D,et al. 1 gTowth differentiation factor 15 as a prognostic marker in patients with acute myocardial infarction[ J]. Eur- Heart, 2009,30 ( 9 ) : 1057-1065.

共引文献320

同被引文献489

引证文献48

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部